Le Lézard
Classified in: Health
Subjects: NPT, CHI, CSR, MAT, DEI

Pleasantrees Partners with Heart 2 Hart to Give Back to Detroit's Homeless Population


The Cannabis Retailer Will Donate Clothing, Supplies in Recognition of Michigan's Homeless Awareness Month

DETROIT, Nov. 8, 2023 /PRNewswire/ -- Pleasantrees is giving back this holiday season in partnership with Detroit-based nonprofit Heart 2 Hart. November is Homeless Awareness Month in Michigan, highlighting ways people can help children and families experiencing homelessness. All month, Pleasantrees will donate one item of clothing for every item purchased from its apparel line, Pleasantrees Provisions.

Pleasantrees is deeply committed to advancing the cause of social equity and improving the lives of those impacted prior to cannabis legalization. One of the core tenets of this commitment is being a "Good Neighbor" in the local communities where Pleasantrees operates (the 4th pillar of its Social Equity Plan). There were reportedly 8,206 homeless individuals in Michigan in 2022, a figure that's on the rise for 2023. With three dispensaries in metro Detroit, Pleasantrees' partnership with Heart 2 Hart kicks off the season of giving close to home.

Heart 2 Hart distributes food, clothing, toiletries, and more to individuals experiencing homelessness. Their mission is "to lift up individuals in crisis and help end homelessness." In 2022, the organization distributed an impressive amount of aid to those in need, including 13,200 meals, 5,200 pairs of socks, and 2,100 shirts and sweatshirts.

Heart 2 Hart's founder and president, Larry Oleinick, was recently recognized as a 2023 Michiganian of the Year by The Detroit News for his valuable contributions to the community. Since founding Heart 2 Hart in 2012, Oleinick has expanded operations from its namesake Hart Plaza to across the metro Detroit area.

In addition to the in-store initiative, Pleasantrees will donate other essential items on Heart 2 Hart's wishlist.

For more information, please visit enjoypleasantrees.com/about/social-equity.

ABOUT PLEASANTREES

Pleasantrees is a vertically-integrated, multi-state cannabis company which prides itself on cultivating the highest quality craft cannabis. It is Michigan's leading wholesaler of medical and recreational cannabis and presently operates five retail establishments in Hamtramck (recreational), Houghton Lake (recreational), East Lansing, Michigan (dual-licensed), Lincoln Park (recreational) and Mount Clemens (dual-licensed). Additionally, the company has world-class cultivation and processing facilities in Harrison Township, Michigan.

The company is committed to cultivating the highest-quality cannabis utilizing a thoughtful, midwestern approach: Working hard so our community can enjoy more of life's pleasures. For more information visit enjoypleasantrees.com.

SOURCE Pleasantrees


These press releases may also interest you

23 fév 2024
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 8, 2024 to file lead plaintiff applications in a securities class action lawsuit against iRhythm Technologies, Inc. , if they purchased the Company's...

23 fév 2024
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 9, 2024 to file lead plaintiff applications in a securities class action lawsuit against Amylyx Pharmaceuticals, Inc. , if they purchased the Company's...

23 fév 2024
The "North America and Europe Managed Equipment Services (MES) Market, Forecast to 2028" report has been added to  ResearchAndMarkets.com's offering. The study period is 2022-2028, with 2023 as the base year and 2024-2028 as the forecast period. The...

23 fév 2024
Easterseals South Florida (ESSF) is proud to announce that Matthew Roth, President of Solstice Point Partners, LLC has been appointed as Board Chair. "My journey at Easterseals South Florida began with a personal connection and commitment to...

23 fév 2024
The "Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country, with Market Analysis, Executive Guides and Customization" report has been added to...

23 fév 2024
Alvotech and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , today announced that the U.S. Food and Drug Administration (FDA) has approved SIMLANDI (adalimumab-ryvk) injection, as an interchangeable biosimilar to...



News published on and distributed by: